Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Nov 24, 2003	Theravance Announces Data on Novel Anesthesia Program Theravance Announces Data on Novel Anesthesia Program SOUTH SAN FRANCISCO, Calif., November 24, 2003 /PRNewswire/ -- Theravance, Inc., today announced that results from a study with its investigational intravenous pharmacokinetically-responsive sedative hypnotic THRX-918661 were recently presented	View HTML Theravance Announces Data on Novel Anesthesia Program 11.2 KB
Toggle Summary Sep 24, 2003	Theravance Announces Promising Results From Multiple Research And Clinical Studies With the Investigational Antibiotic TD-6424 Phase 2 Trials Underway For Serious Infections Caused by Gram-Positive Bacteria	View HTML Theravance Announces Promising Results From Multiple Research And Clinical Studies With the Investigational Antibiotic TD-6424 15.3 KB
Toggle Summary Jan 06, 2003	Theravance and GlaxoSmithKline Form Alliance to Develop Next-Generation Respiratory Medicines Theravance and GlaxoSmithKline Form Alliance to Develop Next-Generation Respiratory Medicines SOUTH SAN FRANCISCO, CA and LONDON, UK Date: January 6, 2003 Theravance, Inc. and GlaxoSmithKline plc (LSE & NYSE: GSK) announced today that they have formed an alliance to develop and commercialize novel	View HTML Theravance and GlaxoSmithKline Form Alliance to Develop Next-Generation Respiratory Medicines 14.9 KB

Investor Relations